MetaLanc9 as a novel biomarker for non-small cell lung cancer: promising treatments via a PGK1-activated AKT/mTOR pathway

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Thorac Dis
Main Authors: De Mello, Ramon Andrade, Aguiar, Pedro Nazareth, Tadokoro, Hakaru, Farias-Vieira, Tállita Meciany, Castelo-Branco, Pedro, de Lima Lopes, Gilberto, Pozza, Daniel Humberto
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2018
Teme:
Editorial
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6036006/
https://ncbi.nlm.nih.gov/pubmed/30023123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.04.122
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki